Big Pharma Watch

BIG PHARMA WATCH: HHS SECRETARY WARNS COVID-19 VACCINE MAKERS OVER “PRICE-GOUGING BEHAVIOR”

Jul 14, 2023

Becerra Encourages Manufacturers to Set “Reasonable” Prices on Upcoming Read More

BIG PHARMA WATCH: BIG PHARMA ALREADY INCREASING PRICES ON NEW RSV VACCINES TO BOOST PROFITS

Jul 13, 2023

Manufacturers Increasing Prices in Lockstep to Raise Prices Across New Drug Read More

BIG PHARMA WATCH: BIG PHARMA EXPOSED FOR CONTINUING TO HIKE PRICES FASTER THAN RATE OF INFLATION

Jun 16, 2023

HHS & CMS Announce New Penalties That Help Hold Brand Name Drug Companies Read More

BIG PHARMA WATCH: BIG PHARMA SPENT $8.1 BILLION ON ADS PUSHING HIGH-PRICED BRAND NAME PRESCRIPTION DRUGS IN 2022

May 1, 2023

Big Pharma Spending Binge Underscores Bipartisan Support for List Price Read More

BIG PHARMA WATCH: NEW REPORT HIGHLIGHTS BIG PHARMA’S RAPIDLY RISING LAUNCH PRICES

Mar 10, 2023

Wall Street Journal Analysis Finds Median Monthly Price for Newly Approved Read More

BIG PHARMA WATCH: NYT REPORT DOCUMENTS NARCOLEPSY DRUG MAKER’S EGREGIOUS EXPLOITATION OF PATENT SYSTEM

Feb 28, 2023

Anti-Competitive Strategy Around Brand Name Narcolepsy Medications Blocked Read More

BIG PHARMA WATCH: U.S. HOUSE REPORT DETAILS “UNJUSTIFIABLY HIGH PRICE” OF UNPROVEN ALZHEIMER’S DRUG ADUHELM

Jan 3, 2023

Congressional Probe Concludes Biogen Set Egregious Price Tag on Aduhelm to Read More

BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST SEVEN DRUGS COST U.S. $805 MILLION IN 2021

Dec 7, 2022

Brand Name Drug Companies Continue Raising Prices on Blockbuster Products With Read More

BIG PHARMA WATCH: MERCK PLOTS TO FURTHER BLOCK COMPETITION AND EXTEND MONOPOLY PRICING ON BLOCKBUSTER CANCER DRUG KEYTRUDA

Dec 2, 2022

Big Pharma Giant Wants New Patents for Formulation Changes That Won’t Read More

BIG PHARMA WATCH: DRUG COMPANY VERTEX PRICE-GOUGING BRAND NAME CYSTIC FIBROSIS TREATMENTS AND BANKING HUGE PROFITS

Nov 30, 2022

Patient Advocates Warn Access to Egregiously Priced Treatments at Risk Drug Read More

BIG PHARMA WATCH: REPRESENTATIVE KATIE PORTER HIGHLIGHTS BIG PHARMA’S OUTRAGEOUS CANCER DRUG LAUNCH PRICES

Nov 3, 2022

New Report Finds Brand Name Drug Companies Increased Prices on New Oncology Read More